Literature DB >> 11548352

Medical radiation usage and exposures from medical X ray diagnosis in Shandong province of China.

L B Li1, J P Wang, X R Yu, S S He, F H Yu, C H Ding.   

Abstract

Shandong province is situated in the eastern part of China with a population of 88 million. A collaborative survey was conducted in 1999 to investigate the medical radiation usage and the patients' exposures from medical X ray diagnosis in this province. There were three stages in this survey: general survey, sampling survey and dose survey. Patients' entrance surface doses (ESD) were measured using thermoluminescence dosemeters (TLDs) attached to the patient's skin. All the hospitals in this province and 2153 patients were included in this survey. The frequencies of tele- and brachytherapy were 1.450 and 1.685 per 1000 population in 1996 and 1998 respectively. The frequency of diagnostic nuclear medicine was 0.325 and 0.412 per 1000 population in 1996 and 1998 respectively; for therapeutic nuclear medicine, it was 0.015 and 0.021. The total annual frequencies of every type of X ray examination and interventional radiology (IVR) in 1996 and 1998 were 179.8 and 200.0 per 1000 population respectively. The main type of X ray examination was chest fluoroscopy, which made up about 39% of the total. The average entrance surface doses were comparatively high for the examinations of CT, gastrointestinal tract, lumbarspine, urography, angiography, hip and cerebral angiography.

Entities:  

Mesh:

Year:  2001        PMID: 11548352     DOI: 10.1093/oxfordjournals.rpd.a006437

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Expression of Bax and Bcl2 Genes in Peripheral Blood Lymphocytes of Patients with Differentiated Thyroid Cancer.

Authors:  Zari Hamivand; Gholamhassan Haddadi; Reza Fardid
Journal:  J Med Phys       Date:  2018 Jan-Mar

2.  Investigation of patient dose from common radiology examinations in Isfahan, Iran.

Authors:  Daryoush Shahbazi-Gahrouei; Milad Baradaran-Ghahfarokhi
Journal:  Adv Biomed Res       Date:  2012-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.